Tags · Clinical
obstructive sleep apnoea
A comorbidity with its own trial evidence in this class.
Related in this group: HbA1c · lipid panel · eGFR & renal function · liver enzymes · thyroid function · lipase & amylase · inflammatory markers · micronutrients · blood pressure · heart rate · type 2 diabetes · chronic kidney disease
32 topics · page 1 of 2
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Injection timing and sleep disruption
Posting this under the heading it deserves: Injection timing and sleep disruption Everything below is what sits behind that. General question, not a request for advice about my own care — I know the…
|
3 | 39k | 3h | |
|
Sleep quality changes during weight loss
On the subject in the title: Sleep quality changes during weight loss Working notes rather than a conclusion. Asking about a population rather than about a person. The published trials in this class mostly…
|
+27 | 31 | 555 | 5h |
|
Second pass at: Sleep apnoea improving and the equipment implications
On the subject in the title: Second pass at: Sleep apnoea improving and the equipment implications Working notes rather than a conclusion. General question, not a request for advice about my own care — I know…
|
+89 | 96 | 1.1k | 10h |
|
Osteoarthritis and mechanical versus metabolic improvement
Osteoarthritis and mechanical versus metabolic improvement Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+2 | 6 | 30k | 12h |
|
Follow-up: Sleep quality changes during weight loss
On the subject in the title: Sleep quality changes during weight loss Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference and I would…
|
+74 | 80 | 4.4k | 14h |
|
Sleep apnoea improving and the equipment implications
Sleep apnoea improving and the equipment implications Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
+14 | 18 | 1.1k | 17h |
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather…
|
+17 | 22 | 4.5k | 1d |
|
Insomnia at a dose step: reported experiences — the long version
Insomnia at a dose step: reported experiences — the long version Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+47 | 51 | 31k | 1d |
|
PCOS and metabolic overlap: what is and is not studied
On the subject in the title: PCOS and metabolic overlap: what is and is not studied Working notes rather than a conclusion. Asking about a population rather than about a person. The published trials in this…
|
3 | 6.6k | 1d | |
|
Revisiting: PCOS and metabolic overlap: what is and is not studied
Revisiting: PCOS and metabolic overlap: what is and is not studied — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published…
|
+55 | 59 | 26k | 2d |
|
Heart failure with preserved ejection fraction: symptom endpoints
Heart failure with preserved ejection fraction: symptom endpoints — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published…
|
+19 | 23 | 311 | 12d |
|
Osteoarthritis and mechanical versus metabolic improvement — one year on
On the subject in the title: Osteoarthritis and mechanical versus metabolic improvement — one year on Working notes rather than a conclusion. General question, not a request for advice about my own care — I…
|
+52 | 56 | 8.1k | 15d |
|
Gastro-oesophageal reflux: improving or worsening?
The question in the title: Gastro-oesophageal reflux: improving or worsening? I will give what I have already checked below so nobody repeats it. Asking about a population rather than about a person. The…
|
+54 | 58 | 8.2k | 1mo |
|
Type 2 diabetes and the largest part of the evidence base
Posting this under the heading it deserves: Type 2 diabetes and the largest part of the evidence base Everything below is what sits behind that. General question, not a request for advice about my own care —…
|
+81 | 89 | 2.9k | 3mo |
|
About the Sleep category
Sleep quality, apnoea, and the bidirectional relationship with metabolic health. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and…
|
+1 | 5 | 92 | 4mo |
|
Cardiovascular risk: reading the outcome trials as a set
Cardiovascular risk: reading the outcome trials as a set Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
4 | 12k | 5mo | |
|
Hepatic steatosis: what the MASH trial evidence supports — one year on
On the subject in the title: Hepatic steatosis: what the MASH trial evidence supports — one year on Working notes rather than a conclusion. General question, not a request for advice about my own care — I…
|
2 | 4.1k | 6mo | |
|
Sleep quality changes during weight loss — what changed since
Sleep quality changes during weight loss — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+68 | 74 | 10k | 8mo |
|
Insomnia at a dose step: reported experiences
On the subject in the title: Insomnia at a dose step: reported experiences Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference and I…
|
+20 | 24 | 18k | 8mo |
|
Revisiting: Gallbladder disease risk with rapid weight loss
Revisiting: Gallbladder disease risk with rapid weight loss Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
2 | 2k | 9mo | |
|
Sleep tracking data and its considerable limitations
Sleep tracking data and its considerable limitations — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this…
|
+109 | 126 | 61k | 9mo |
|
[2026 update] Cardiovascular risk: reading the outcome trials as a set
Posting this under the heading it deserves: Cardiovascular risk: reading the outcome trials as a set Everything below is what sits behind that. Asking about a population rather than about a person. The…
|
+99 | 103 | 32k | 11mo |
|
Second pass at: Sleep tracking data and its considerable limitations
Posting this under the heading it deserves: Second pass at: Sleep tracking data and its considerable limitations Everything below is what sits behind that. Asking about a population rather than about a…
|
2 | 59 | 12mo | |
|
Hepatic steatosis: what the MASH trial evidence supports
Hepatic steatosis: what the MASH trial evidence supports — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in…
|
+77 | 83 | 950 | 13mo |
|
Obstructive sleep apnoea and a hard endpoint in this class
On the subject in the title: Obstructive sleep apnoea and a hard endpoint in this class Working notes rather than a conclusion. Asking about a population rather than about a person. The published trials in…
|
+120 | 129 | 1.8k | 13mo |
|
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The…
|
2 | 726 | 14mo | |
|
Injection timing and sleep disruption — the long version
Injection timing and sleep disruption — the long version — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in…
|
2 | 164 | 16mo | |
|
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. General question, not a request for advice about my own care…
|
+4 | 8 | 43k | 17mo |
|
Gallbladder disease risk with rapid weight loss
Posting this under the heading it deserves: Gallbladder disease risk with rapid weight loss Everything below is what sits behind that. General question, not a request for advice about my own care — I know the…
|
+56 | 63 | 34k | 18mo |
|
Hypertension improvement and when medication needs revisiting — a second dataset
Posting this under the heading it deserves: Hypertension improvement and when medication needs revisiting — a second dataset Everything below is what sits behind that. General question, not a request for…
|
+126 | 133 | 22k | 21mo |
Sponsored
Janoshik Analytical — independent third-party testingHPLC purity and mass-spectrometric identity on submitted samples, reported with the method stated. The laboratory most often cited in this community’s verification records.Independent testing →
Sponsored
GL Biochem (Shanghai) Ltd. — synthesis, directFounded 1998. ISO 9001 and cGMP certified, over 1,500 staff and 200-plus patents. Custom peptide synthesis and amino acid derivatives, with a batch certificate on every order.Custom synthesis →